Prairie Du Chien Memorial Hospital Association INC
Prairie Du Chien Memorial Hospital Association INC was paid $6.93M by Medicaid between Jan 2018 and Nov 2024, across 105 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 20% of everything it billed.
PRAIRIE DU CHIEN, WI 53821
Next to other Critical Access Hospital providers in Wisconsin
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,309 | $806K | |
| 2019 | 15,224 | $790K | |
| 2020 | 9,895 | $675K | |
| 2021 | 14,402 | $846K | |
| 2022 | 18,046 | $1.18M | |
| 2023 | 25,983 | $1.37M | |
| 2024incomplete | 22,423 | $1.27M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 20% | 5,923 | 5,103 | $1.36M |
| 96361 | Intravenous infusion, hydration; each additional hour | 14% | 1,940 | 1,597 | $969K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.2% | 5,438 | 3,861 | $635K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.2% | 4,906 | 4,276 | $571K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.9% | 2,475 | 2,119 | $551K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7.6% | 2,200 | 1,410 | $529K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6.6% | 3,485 | 3,083 | $460K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.5% | 1,510 | 1,310 | $310K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 2,684 | 2,047 | $287K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.8% | 893 | 571 | $194K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.0% | 653 | 570 | $138K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 1,623 | 1,405 | $116K |
93 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 2,824 | $92K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.3% | 4,208 | $90K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 285 | $62K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,305 | $62K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,623 | $57K |
| 80053 | Comprehensive metabolic panel | <1% | 6,870 | $46K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 244 | $43K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 734 | $39K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 239 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,230 | $30K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 74 | $21K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,050 | $19K |
| 84484 | <1% | 3,078 | $14K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 56 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 165 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,105 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,258 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 988 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,950 | $10K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 208 | $10K |
| 81001 | <1% | 3,031 | $9K | |
| 83690 | <1% | 1,934 | $8K | |
| 87631 | <1% | 98 | $7K | |
| 85379 | <1% | 1,237 | $6K | |
| 82150 | <1% | 1,661 | $6K | |
| 83735 | <1% | 2,017 | $6K | |
| 86140 | <1% | 2,012 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,233 | $5K |
| 81025 | <1% | 746 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,049 | $4K |
| 83605 | <1% | 1,155 | $4K | |
| 84145 | <1% | 519 | $4K | |
| 83880 | <1% | 424 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 450 | $4K |
| 99350 | Prolong home eval add 15m | <1% | 142 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,082 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,038 | $3K |
| 82962 | <1% | 1,750 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 40 | $2K |
| 81003 | <1% | 1,308 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 17 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 143 | $2K |
| 85610 | <1% | 1,358 | $2K | |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 44 | $2K |
| 82550 | <1% | 671 | $2K | |
| 87040 | <1% | 624 | $1K | |
| 87077 | <1% | 329 | $1K | |
| 80306 | <1% | 109 | $1K | |
| 87634 | <1% | 20 | $1K | |
| 85730 | <1% | 520 | $1K | |
| 85652 | <1% | 700 | $1K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 57 | $1K |
| 87186 | <1% | 247 | $980.41 | |
| 74022 | <1% | 222 | $933.08 | |
| 87081 | <1% | 110 | $849.21 | |
| 82077 | <1% | 88 | $818.88 | |
| 80050 | General health panel | <1% | 95 | $695.44 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 198 | $599.95 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 19 | $594.00 |
| 85027 | <1% | 147 | $487.44 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 16 | $400.91 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,881 | $317.18 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $297.76 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 19 | $267.31 |
| 97162 | <1% | 13 | $250.64 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 13 | $250.00 |
| 73630 | <1% | 17 | $231.32 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,555 | $214.78 |
| 73030 | <1% | 17 | $181.40 | |
| 96127 | <1% | 18 | $176.40 | |
| 73562 | <1% | 14 | $131.38 | |
| 96376 | <1% | 49 | $102.10 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,191 | $101.46 |
| 80061 | Lipid panel | <1% | 13 | $82.14 |
| 94664 | <1% | 71 | $66.09 | |
| J3490 | Unclassified drugs | <1% | 283 | $64.73 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,031 | $54.57 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15 | $52.65 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,765 | $37.98 |
| 85007 | <1% | 15 | $23.74 | |
| G0378 | Hospital observation service, per hour | <1% | 34 | $8.54 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 739 | $7.44 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 234 | $5.79 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 91 | $3.14 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 326 | $3.12 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 123 | $2.14 |
| J2704 | Injection, propofol, 10 mg | <1% | 319 | $1.18 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 229 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 134 | $0.00 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 15 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 47 | $0.00 |
| A4606 | Oxygen probe for use with oximeter device, replacement | 0% | 88 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Prairie Du Chien Memorial Hospital Assoc INC | Prairie Du Chien, WI | $538K |
| Prairie Du Chien Memorial Hospital Association INC | Prairie Du Chien, WI | $81K |
| Prairie Du Chien Memorial Hospital Association INC | Prairie Du Chien, WI | $59K |
| Prairie Du Chien Memorial Hospital Assoc INC | Fennimore, WI | $27K |
| Prairie Du Chien Memorial Hospital | Prairie Du Chien, WI | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.